214 related articles for article (PubMed ID: 7684460)
1. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway.
Kimata JT; Palker TJ; Ratner L
J Virol; 1993 Jun; 67(6):3134-41. PubMed ID: 7684460
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
[TBL] [Abstract][Full Text] [Related]
3. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.
Dodon MD; Bernard A; Gazzolo L
J Virol; 1989 Dec; 63(12):5413-9. PubMed ID: 2573739
[TBL] [Abstract][Full Text] [Related]
5. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.
Koyasu S; Lawton T; Novick D; Recny MA; Siliciano RF; Wallner BP; Reinherz EL
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2603-7. PubMed ID: 1690889
[TBL] [Abstract][Full Text] [Related]
6. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
[TBL] [Abstract][Full Text] [Related]
7. Accessory cell-dependent T-cell activation via Ti-CD3. Involvement of CD2-LFA-3 interactions.
Halvorsen R; Leivestad T; Gaudernack G; Thorsby E
Scand J Immunol; 1988 Sep; 28(3):277-84. PubMed ID: 2461580
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction.
Hughes CC; Savage CO; Pober JS
J Exp Med; 1990 May; 171(5):1453-67. PubMed ID: 1692079
[TBL] [Abstract][Full Text] [Related]
9. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
10. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
11. The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways.
Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; de Waal RM
Transpl Immunol; 1993; 1(3):183-91. PubMed ID: 7521739
[TBL] [Abstract][Full Text] [Related]
12. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
13. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.
Wucherpfennig KW; Höllsberg P; Richardson JH; Benjamin D; Hafler DA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2110-4. PubMed ID: 1549569
[TBL] [Abstract][Full Text] [Related]
14. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of T cell activation and adhesion functions by soluble CD2 protein.
Rabin EM; Gordon K; Knoppers MH; Luther MA; Neidhardt EA; Flynn JF; Sardonini CA; Sampo TM; Concino MF; Recny MA
Cell Immunol; 1993 Jun; 149(1):24-38. PubMed ID: 7685660
[TBL] [Abstract][Full Text] [Related]
16. Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines.
Fukudome K; Furuse M; Fukuhara N; Orita S; Imai T; Takagi S; Nagira M; Hinuma Y; Yoshie O
Int J Cancer; 1992 Sep; 52(3):418-27. PubMed ID: 1356935
[TBL] [Abstract][Full Text] [Related]
17. The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells.
Tiefenthaler G; Hünig T
Int Immunol; 1989; 1(2):169-75. PubMed ID: 2484882
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of LFA-3 on human T-cell lines and leukemic cells carrying human T-cell-leukemia virus type 1.
Imai T; Tanaka Y; Fukudome K; Takagi S; Araki K; Yoshie O
Int J Cancer; 1993 Nov; 55(5):811-6. PubMed ID: 7503960
[TBL] [Abstract][Full Text] [Related]
19. Signaling from LFA-1 contributes signal transduction through CD2 alternative pathway in T cell activation.
Yamada A; Kaneyuki T; Torimoto Y; Daley JF; Prado CM; Yokoyama MM
Cell Immunol; 1992 Jun; 142(1):145-58. PubMed ID: 1375131
[TBL] [Abstract][Full Text] [Related]
20. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
